Investing in tomorrow's medicine
Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.
News
CEVA COMPLETES ACQUISITION OF IDT VETERINARY BUSINESS ASSETS, MOVING CLOSER TO ITS 2020 OBJECTIVE OF 50:50 BIO-PHARMA SPLIT
03/07/2019
Ceva and IDT have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R&D activities by Ceva.
SuperSonic Imagine announces that it has received a binding offer from the Hologic group to acquire 100% of the Company’s capital for a price of €1.50 per share
21/06/2019
Hologic is planning to acquire a controlling stake of approximately 46% of the Company’s capital.
Xeris Pharmaceuticals Announces Additional Positive Outcomes from a Global Phase 3 Clinical Trial of Its Investigational Ready-to-Use Glucagon
17/06/2019
Findings will support application for European marketing authorization and augment body of data supporting efficacy and utility of its stable liquid glucagon.
Key figures
25
20
525
(€ million)
3
